151 related articles for article (PubMed ID: 32414345)
1. Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells.
Moore C; Palau VE; Mahboob R; Lightner J; Stone W; Krishnan K
BMC Cancer; 2020 May; 20(1):428. PubMed ID: 32414345
[TBL] [Abstract][Full Text] [Related]
2. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
3. Gamma-tocopherol induces apoptosis in androgen-responsive LNCaP prostate cancer cells via caspase-dependent and independent mechanisms.
Jiang Q; Wong J; Ames BN
Ann N Y Acad Sci; 2004 Dec; 1031():399-400. PubMed ID: 15753180
[TBL] [Abstract][Full Text] [Related]
4. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
5. Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
Gazi MH; Gong A; Donkena KV; Young CY
Clin Chim Acta; 2007 May; 380(1-2):145-50. PubMed ID: 17346688
[TBL] [Abstract][Full Text] [Related]
6. γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer.
Campbell SE; Rudder B; Phillips RB; Whaley SG; Stimmel JB; Leesnitzer LM; Lightner J; Dessus-Babus S; Duffourc M; Stone WL; Menter DG; Newman RA; Yang P; Aggarwal BB; Krishnan K
Free Radic Biol Med; 2011 May; 50(10):1344-54. PubMed ID: 21335085
[TBL] [Abstract][Full Text] [Related]
7. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
Galli F; Stabile AM; Betti M; Conte C; Pistilli A; Rende M; Floridi A; Azzi A
Arch Biochem Biophys; 2004 Mar; 423(1):97-102. PubMed ID: 14871472
[TBL] [Abstract][Full Text] [Related]
8. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
[TBL] [Abstract][Full Text] [Related]
9. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
10. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis.
Jiang Q; Wong J; Fyrst H; Saba JD; Ames BN
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17825-30. PubMed ID: 15596715
[TBL] [Abstract][Full Text] [Related]
11. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase.
Ghosh J
Biochem Biophys Res Commun; 2003 Jul; 307(2):342-9. PubMed ID: 12859962
[TBL] [Abstract][Full Text] [Related]
13. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
15. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways.
Zhang D; Liu H; Yang B; Hu J; Cheng Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975734
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines.
Campbell SE; Stone WL; Lee S; Whaley S; Yang H; Qui M; Goforth P; Sherman D; McHaffie D; Krishnan K
BMC Cancer; 2006 Jan; 6():13. PubMed ID: 16417629
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
19. Androgen and the blocking of radiation-induced sensitization to Fas-mediated apoptosis through c-jun induction in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
Int J Radiat Biol; 2003 Jun; 79(6):451-62. PubMed ID: 12963547
[TBL] [Abstract][Full Text] [Related]
20. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
